Translate this page to:
In JoVE (1)
- Количественная оценка активности атеросклеротического налета и воспаления сосудистой помощи [18 F] фтордезоксиглюкозы позитронно-эмиссионной томографии / компьютерной томографии (FDG-PET/CT)
Other Publications (1)
This translation into Russian was automatically generated.
English Version | Other Languages
Articles by Joel M. Gelfand in JoVE
Количественная оценка активности атеросклеротического налета и воспаления сосудистой помощи [18 F] фтордезоксиглюкозы позитронно-эмиссионной томографии / компьютерной томографии (FDG-PET/CT)
Nehal N. Mehta1, Drew A. Torigian2, Joel M. Gelfand3, Babak Saboury2, Abass Alavi2
1Division of Cardiovascular Medicine, University of Pennsylvania, Perelman School of Medicine, 2Department of Radiology, University of Pennsylvania, Perelman School of Medicine, 3Department of Dermatology, University of Pennsylvania, Perelman School of Medicine
Существует большая необходимость выявления атеросклероза неинвазивным, и здесь мы демонстрируем FDG-PET/CT может быть использована для выявления и количественной атеросклеротической бляшки деятельности и сосудистого воспаления.
Other articles by Joel M. Gelfand on PubMed
Experimental Dermatology. Jun, 2010 | Pubmed ID: 20456495
Curcuminoids exhibit anti-proliferative properties in many cell lines by modulating signalling pathways to inhibit cell growth. However, the specific effects of curcuminoids on human keratinocytes are not well defined, and this situation impairs mechanistic thinking regarding potential therapeutic uses. We hypothesized that curcuminoids would modulate key growth regulatory pathways in keratinocytes to inhibit cell proliferation. To test this hypothesis, the effects of curcumin and tetrahydrocurcumin (THC) on mitogen-activated protein (MAP) kinase signalling in keratinoctyes were determined. Primary human keratinocytes treated with curcumin or THC demonstrated decreased activation of p44/42 MAP kinases but increased levels of activated p38 MAP kinases. These data suggest that curcuminoids specifically activate stress-induced MAP kinases while inhibiting mitogen-induced MAP kinases. Curcuminoids also promote the phosphorylation of p53 on serine 15 in a dose-dependent and p38-dependent manner, suggesting that these compounds may activate p53. The effects of curcuminoids on keratinocytes mirrored some aspects of UVB and could be inhibited by N-acetylcysteine, suggesting that these compounds activate p38 through a mechanism that involves glutathione depletion. Both curcuminoids induced G2/M block and inhibited keratinocyte growth, and THC increased cellular levels of p21, a known p53 transcriptional target. These data demonstrate that curcuminoids can differentially regulate MAP kinases to inhibit keratinocyte growth while inducing p21. Curcuminoids also synergize with UVB to enhance p53 phosphorylation. The findings provide a rationale for testing curcuminoids in disorders associated with impaired p53 function or in which UVB-treatment is efficacious.